Figures and tables index

From the following article

Antivirals become a broader enterprise

Jeffrey L Fox

Nature Biotechnology 25, 1395 - 1402 (2007)

doi:10.1038/nbt1207-1395

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 1

Antiviral therapeutics market.

Full size figure and legend (21 KB)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 2

HIV live cycle and points of intervention by antiviral drugs.

Full size figure and legend (84 KB)
Figure 3 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 3

Market growth of in vitro diagnostics by sector from 2002–2006 with projections for 2007–2009.

Full size figure and legend (33 KB)
Figure 4 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 4

Activation of innate immune system by TRLs.

Full size figure and legend (84 KB)
Table 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Table 1

Selected antivirals in clinical trials

Full size table and legend
Table 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Table 2

Selected companies with antivirals in preclinical development

Full size table and legend
BACK TO ARTICLE